Black Friday: 40% off your first annual payment. Ends 30 November. View offer

ProQR Therapeutics NV (PRQR)

ProQR Therapeutics NV experienced multiple insider purchases during June and July 2026. Chief Executive Officer Daniel Anton de Boer and Bart Filius acquired significant equity stakes, with the final transactions occurring on July 31, 2026. These acquisitions represent the most recent activity recorded for the firm, occurring well beyond the three-month window.
Ticker: PRQR Exchange: NAS


Loading...
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for ProQR Therapeutics NV. Upgrade to see score, net flow, insiders and the full signal context.

Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
2.0
de Boer Daniel Anton Chief Executive Officer Executive Director
Transaction date
Purchase
Price
260.65
Quantity 49,249 +3.7%
Value US$4,283,441
2.0
de Boer Daniel Anton Chief Executive Officer Executive Director
Transaction date
Purchase
Price
391.00
Quantity 74,457 +19.1%
Value US$2,018,246
2.2
Filius Bart Non-Executive Director
Transaction date
Purchase
Price
74.82
Quantity 82,558 -28.1%
Value US$1,573,913
2.0
de Boer Daniel Anton Chief Executive Officer Executive Director
Transaction date
Purchase
Price
1.74
Quantity 150,000 +100.0%
Value US$261,000
2.0
de Boer Daniel Anton Chief Executive Officer Executive Director
Transaction date
Purchase
Price
1.59
Quantity 150,000 New position
Value US$238,500
2.2
Filius Bart Non-Executive Director
Transaction date
Purchase
Price
1.54
Quantity 150,000 New position
Value US$231,000
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value
Number of shares Price Value Details
2026-08-03 2026-07-31 B Purchase

Chief Executive Officer

Executive Director
49,249 +3.7%
260.65
US$4,283,441
49,249 +3.7% 260.65 US$4,283,441
2026-08-03 2026-07-31 B Purchase

Chief Executive Officer

Executive Director
74,457 +19.1%
391.00
US$2,018,246
74,457 +19.1% 391.00 US$2,018,246
2026-07-21 2026-07-17 B Purchase Non-Executive Director
82,558 -28.1%
74.82
US$1,573,913
82,558 -28.1% 74.82 US$1,573,913
2026-07-13 2026-07-09 B Purchase

Chief Executive Officer

Executive Director
150,000 +100.0%
1.74
US$261,000
150,000 +100.0% 1.74 US$261,000
2026-07-08 2026-07-07 B Purchase

Chief Executive Officer

Executive Director
150,000 New position
1.59
US$238,500
150,000 New position 1.59 US$238,500
2026-06-30 2026-06-26 B Purchase Non-Executive Director
150,000 New position
1.54
US$231,000
150,000 New position 1.54 US$231,000